TranS1

TranS1 is a medical device company focused on innovative, minimally invasive surgical solutions for spine procedures. The company aims to reduce tissue damage associated with traditional spinal surgeries, enhancing outcomes for patients and surgeons. Their approach, "Building Better Pathways™," addresses unmet clinical needs and delivers value-based solutions in healthcare. TranS1's flagship products include the AxiaLIF+ System, which provides a safe anterior access route to the L5-S1 vertebral bodies, minimizing surgical trauma. The Vectre™ Facet Fusion System offers a posterior fixation method that reduces muscle and tissue trauma during spinal fusion procedures. The company collaborates with leading spine surgeons to advance technology and improve patient care. With a team of experts in minimally invasive spine surgery, TranS1 supports spine surgeons with training and resources to adopt their technologies. The company is led by CEO Robert L. Bundy, who has over 40 years of industry experience and is dedicated to improving spine surgery outcomes.

• Employees 27
• Founded 2015